Table 1.

Comparison of Alzheimer’s disease groups with cerebrovascular disease (AD+CVD) and without cerebrovascular disease (AD−CVD) on demographic characteristics, and clinical and vascular risk factors

	AD+CVD	AD−CVD
Age (years)	74.4 ± 7.4	73.4 ± 5.9
Men/women ratio (% Men)	23/26 (46.9%)	8/8 (50.0%)
Education (years)	12.8 ± 3.2	13.0 ± 3.1
Antihypertensives (% on meds)	14 (28.6%)	4 (25.0%)
DRS score (raw)	105.2 ± 22.7	91.6 ± 27.3
Time-to-death (years)	6.4 ± 3.3	4.4 ± 2.3*
APOE4 (% with ε4 allele)	36 (73.5%)	10 (62.5%)
APOE genotype
33	13 (26.5%)	6 (37.5%)
34	24 (49.0%)	9 (56.3%)
44	10 (20.4%)	1 (6.3%)
42	2 (4.1%)	0 (0%)
Cardiovascular disease	20 (40.8%)	5 (31.3%)
TIA/Stroke	7 (14.3%)	0 (0%)
Diabetes	6 (12.2%)	0 (0%)
Atrial fibrillation	5 (10.2%)	0 (0%)
Left ventricular hypertrophy	0 (0%)	0 (0%)
≥ 2 Vascular risk factors	10 (20.4%)	0%*

Values indicate mean ± standard deviation or number of cases (% of cases).

^*p < 0.05.